Placebo News and Research

RSS

Vitamin D supplementation reduces risk of major cardiovascular events in older adults

Research investigates the impact of vitamin D supplementation on the incidence of major cardiovascular events in older adults. It examines whether monthly doses of vitamin D can alter the occurrence of heart-related problems.

4 Jul 2023

Critical questions raised for evaluation of anti-amyloid immunotherapies in Alzheimer's treatment

Anti-amyloid immunotherapies for Alzheimer's disease require thorough evaluation of their efficacy, safety, and cost-effectiveness. Key questions regarding statistical analyses, treatment effects, and disease course modification guide evidence-based consideration of these drugs.

4 Jul 2023

Breaking the myth: opioids provide no advantage for acute back pain, study finds

The first placebo-controlled trial of opioids in acute low back and neck pain.

3 Jul 2023

Vitamin D supplements may reduce risk of heart attacks in people over 60

Vitamin D supplements may reduce the risk of major cardiovascular events such as heart attacks among people aged over 60, finds a clinical trial published by The BMJ today.

3 Jul 2023

Towards Zika preparedness: immunogenicity insights from vaccine research

Study assesses the safety and immunogenicity of an inactivated Zika virus vaccine candidate.

30 Jun 2023

TOS members unveil new research about anti-obesity medications at ADA annual meeting

Multiple members of The Obesity Society (TOS) unveiled new research about several anti-obesity medications in development at this year's annual meeting of the American Diabetes Association (ADA) held June 23–26.

29 Jun 2023

Tirzepatide triumphs in significant weight reduction for people with type 2 diabetes

Researchers performed a double-blinded, placebo-controlled phase III randomized clinical trial (RCT).

29 Jun 2023

The Lancet study unveils exciting findings on retatrutide as a novel treatment for type 2 diabetes

Researchers performed a phase II randomized clinical trial (RCT).

29 Jun 2023

Study reveals oral Semaglutide 50 mg as promising treatment for obesity in adults: the Lancet report

Researchers performed a phase III randomized clinical trial (RCT).

29 Jun 2023

Vitamin D supplements may reduce risk of heart attacks in older adults

Vitamin D supplements may reduce the risk of major cardiovascular events such as heart attacks among people aged over 60, finds a clinical trial published by The BMJ today.

28 Jun 2023

Trial shows no benefit of prescribing an opioid for people with acute back or neck pain

Opioid pain-relieving medicines are not more effective than a placebo in relieving acute back and neck pain and may even cause harm, according to a world-first trial led by the University of Sydney.

28 Jun 2023

New drug effective as a treatment against ulcerative colitis, clinical trial shows

A new drug, investigated by Amsterdam UMC together with colleagues around the world, is effective as a treatment against ulcerative colitis.

28 Jun 2023

Blood pressure lowering medications could be used more widely to prevent migraines

The first known large-scale review of international studies on the positive effect of blood pressure (BP) medicines across all classes in preventing migraine shows these widely available drugs could be used much more widely, at low cost, than is the case with current practice, according to a new paper published today in the journal, Cephalalgia.

27 Jun 2023

Placebo News and Research

Vitamin D supplementation reduces risk of major cardiovascular events in older adults

Critical questions raised for evaluation of anti-amyloid immunotherapies in Alzheimer's treatment

Breaking the myth: opioids provide no advantage for acute back pain, study finds

Vitamin D supplements may reduce risk of heart attacks in people over 60

Towards Zika preparedness: immunogenicity insights from vaccine research

TOS members unveil new research about anti-obesity medications at ADA annual meeting

Tirzepatide triumphs in significant weight reduction for people with type 2 diabetes

The Lancet study unveils exciting findings on retatrutide as a novel treatment for type 2 diabetes

Study reveals oral Semaglutide 50 mg as promising treatment for obesity in adults: the Lancet report

Vitamin D supplements may reduce risk of heart attacks in older adults

Trial shows no benefit of prescribing an opioid for people with acute back or neck pain

New drug effective as a treatment against ulcerative colitis, clinical trial shows

Blood pressure lowering medications could be used more widely to prevent migraines

Higher-than-recommended doses of vitamin D linked to lower risk of atrial fibrillation

Researchers identify a potential new drug for NASH-related fibrosis

Viral clearance: A potential predictor of COVID-19 treatment efficacy

First successful Phase 2 trial uses cutting-edge RNA CAR-T therapy to treat autoimmunity

Do Panax notoginseng saponins (Xuesaitong soft capsules) improve function in patients with ischemic stroke?

Ketone supplements used by some athletes may worsen performance

Hypertension drug shown to prevent post-traumatic headaches

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News